about
The Valley of Death in anticancer drug development: a reassessmentRecent advances in postoperative pain management.A thermo-responsive protein treatment for dry eyes.Reversion of pH-induced physiological drug resistance: a novel function of copolymeric nanoparticlesAtomic force microscopy images label-free, drug encapsulated nanoparticles in vivo and detects difference in tissue mechanical properties of treated and untreated: a tip for nanotoxicologyIntelligently targeted drug delivery and enhanced antitumor effect by gelatinase-responsive nanoparticlesPaliperidone ER: a review of the clinical trial data.Visualization of drug delivery processes using AIEgensInvestigation of endocytosis and cytotoxicity of poly-d, l-lactide-poly(ethylene glycol) micro/nano-particles in osteoblast cells.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Preparation and characterization of a lecithin nanoemulsion as a topical delivery systemAdvances in NSAID development: evolution of diclofenac products using pharmaceutical technologyμ-Opioid receptor antibody reveals tissue-dependent specific staining and increased neuronal μ-receptor immunoreactivity at the injured nerve trunk in miceDrug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus.Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO Micro Infusion Pump: Programmable, Refillable, and Implantable.Efficient delivery of ursolic acid by poly(N-vinylpyrrolidone)-block-poly (ε-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivoTumor-targeted drug delivery with aptamersEnhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.Reservoir-based drug delivery systems utilizing microtechnology.The performance of nanocarriers for transmucosal drug delivery.Optimized formulation of solid self-microemulsifying sirolimus delivery systemsNanomedicines in renal transplant rejection--focus on sirolimusImpact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo.Nitric oxide-releasing xerogels synthesized from N-diazeniumdiolate-modified silane precursorsProspects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.Scalable method to produce biodegradable nanoparticles that rapidly penetrate human mucusMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.Nanoparticles as protein and gene carriers to mucosal surfaces.Magnetic separation of general solid particles realised by a permanent magnet.Controlled delivery systems: from pharmaceuticals to cells and genes.Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.Engineering immunity in the mucosal niche against sexually transmitted infections.Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives.Anti-proliferative and antibacterial in vitro evaluation of the polyurethane nanostructures incorporating pentacyclic triterpenes.Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.Injectable small molecule hydrogel as a potential nanocarrier for localized and sustained in vivo delivery of doxorubicin.Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer.Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.Continuous Delivery of Neutralizing Antibodies Elevate CCL2 Levels in Mice Bearing MCF10CA1d Breast Tumor Xenografts.Newer drug delivery systems in anesthesia.
P2860
Q26861274-4D6CC721-5D06-4E01-B5D6-37AC083DB1D6Q27692684-3CB7EA23-998A-4634-8BB0-C6947B2CD766Q28115093-CA813DD3-CE42-43B9-AB19-2B9385C0658DQ28477221-EFF8CD91-0339-422E-AE88-398A7381BADFQ28533356-334CA645-7700-4270-97D2-2C94404198A4Q28534995-00A2715B-03D7-46A2-8FB0-981CB825FA9BQ33419885-C4797B54-56A4-4844-9037-B87A44630B00Q33686487-9EE95F61-4149-4A0B-B73A-3DA18C82ECA7Q33721938-33CA5004-DC35-408F-A939-3DE20177B6CCQ33902253-C20E6C6E-DA46-4346-BD43-2F64D3ADF436Q33949314-E0ED6B5F-8EB4-4934-82A0-063FEB61BE66Q34475981-2D999D52-577B-426E-B6C5-B6BB610426AAQ35053136-AEB317DA-2C62-4586-9156-D7FE54FBC926Q35087552-E6331554-CD31-4898-B78D-E612A31C8292Q35144336-1D531323-7BAD-4EDE-BA6E-D568D3A4A534Q35185783-63D871FE-0144-4A15-BDB4-8D6D22B54087Q35490874-213A0285-8B47-49D0-9110-9FB4BD3AADF5Q35592271-C33B7294-E4B4-4FBF-9AFD-F0426CDF65A2Q36198990-93F69151-F380-4A4F-85F8-DB886C50ECB5Q36527739-E806E64A-369C-44C1-9E35-69CA39DA3591Q36805040-ED740061-BDA0-43B1-AC5C-5D0C4707C793Q36920414-CDFE16A5-B279-4735-A20D-77ECAAD08F70Q36961634-F20EEC6D-28FC-4F1A-AC79-54E04C5DEE58Q36979307-98C3688A-0333-4D7D-BA25-386C39E40AD8Q36985913-FD594772-C0C3-4C93-A27A-2796F303F8C4Q37062353-FC5131D5-BE9A-46E1-B2E3-5B5883794BBAQ37153923-7B921A91-6E9B-45DC-BFE5-9F586D561345Q37331802-BAD4DC5F-7464-4F82-B2F9-00A989CA70CCQ37483734-C11C4C91-615A-4FF3-838F-BB93B4F510D7Q37855597-4E55BE45-680C-4477-8DFC-3121E1309DA0Q38222809-DCC0032D-B7D3-4FDB-8BCC-4A803D418F0EQ38543768-CDA343D9-A10B-4118-8AD4-28A16E3496FEQ38732021-C0E89F38-CC59-4FB4-902C-F278AE6938B4Q38772286-77B456DB-09AB-485D-B328-988087DADCD1Q38789348-D12DF86C-3B56-4C74-A629-510CC2E98BD7Q38956013-1C3EBCF8-FBF3-40A7-9499-19FE3B5C8079Q39137149-334E4FE0-40FC-434D-A0F0-ED46CE57572EQ39479822-0BC4145C-E3CC-41C4-8A8E-93E9DA8641D2Q40124047-4960820D-ACF0-4ADE-BF63-96A549F29086Q41081606-5E217F6E-2ECE-4569-9B98-5117AA17F352
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The rise and rise of drug delivery.
@ast
The rise and rise of drug delivery.
@en
type
label
The rise and rise of drug delivery.
@ast
The rise and rise of drug delivery.
@en
prefLabel
The rise and rise of drug delivery.
@ast
The rise and rise of drug delivery.
@en
P2860
P356
P1476
The rise and rise of drug delivery.
@en
P2093
Howard Rosen
Thierry Abribat
P2860
P2888
P304
P356
10.1038/NRD1721
P577
2005-05-01T00:00:00Z